Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet

Core Viewpoint - Immunocore Holdings PLC (IMCR) has seen a 6.4% increase in share price over the past four weeks, closing at $30.47, with analysts suggesting a potential upside of 107.5% based on a mean price target of $63.21 [1] Price Targets - The average of 14 short-term price targets ranges from a low of $24 to a high of $100, with a standard deviation of $23.20, indicating variability among analysts [2] - The lowest estimate suggests a decline of 21.2% from the current price, while the highest estimate indicates a potential upside of 228.2% [2] Analyst Consensus and Earnings Estimates - Analysts are increasingly optimistic about IMCR's earnings prospects, as evidenced by a strong agreement in revising EPS estimates higher, which correlates with potential stock price increases [4][11] - The Zacks Consensus Estimate for the current year has risen by 3.9% over the past month, with one estimate increasing and no negative revisions [12] Zacks Rank - IMCR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13]